Philip M Clarke Selected Research

Philip M Clarke Research Topics

8	Type 2 Diabetes Mellitus (MODY) 01/2020 - 07/2006
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2022 - 06/2013
3	Stroke (Strokes) 11/2014 - 01/2009
3	Diabetes Complications 06/2013 - 01/2009
2	Malaria 10/2017 - 03/2011
2	Myocardial Infarction 11/2014 - 06/2013
2	Blindness (Hysterical Blindness) 06/2013 - 06/2013
2	Heart Failure 06/2013 - 01/2009
1	COVID-19 10/2022
1	Diabetes Mellitus 03/2020
1	Vivax Malaria 10/2017
1	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2017
1	Weight Loss (Weight Reduction) 07/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2013
1	Renal Insufficiency (Renal Failure) 06/2013
1	Disease Progression 07/2011
1	Vascular Diseases (Vascular Disease) 02/2010
1	Coronary Disease (Coronary Heart Disease) 01/2009
1	Ulcer 01/2009
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2006
1	Eye Diseases (Eye Disease) 07/2006

3	Insulin (Novolin)FDA Link 09/2021 - 05/2010
2	Blood Glucose (Blood Sugar)IBA 11/2022 - 06/2013
2	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2018
2	CarbohydratesIBA 09/2021 - 01/2018
2	artemisinin (artemisinine)IBA 10/2017 - 03/2011
2	HDL CholesterolIBA 06/2013 - 04/2009
2	LipidsIBA 05/2010 - 07/2006
1	VaccinesIBA 10/2022
1	Triglycerides (Triacylglycerol)IBA 03/2020
1	AlbuminsIBA 03/2020
1	CreatinineIBA 03/2020
1	empagliflozinIBA 01/2020
1	CanagliflozinIBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 10/2017
1	Antimalarials (Antimalarial Agents)IBA 10/2017
1	naphthoquineIBA 10/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2014
1	Fenofibrate (CiL)FDA LinkGeneric 01/2009

5	Therapeutics 09/2021 - 07/2006
3	Surgical Amputation (Amputations) 06/2013 - 01/2009
2	Injections 09/2021 - 01/2018
1	Glycemic Control 01/2018
1	Bariatric Surgery 07/2017
1	Ambulatory Care (Outpatient Care) 11/2014
1	Length of Stay 02/2010
1	Renal Dialysis (Hemodialysis) 01/2009